Somewhat Positive Press Coverage Likely to Impact Esperion Therapeutics (ESPR) Share Price

Somewhat Positive Press Coverage Likely to Impact Esperion Therapeutics (ESPR) Share Price


Press coverage about Esperion Therapeutics has trended somewhat positive recently, according to AlphaOne Sentiment Analysis. The research group, a service of Accern, ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources in real time.



from Biotech News